Big Pharma’s focus on profit is behind medicine shortages, superbug threat | Health
What happens when we run out of medicines? Medical authorities around the world are pondering this question as they struggle with shortages of a range…
Biden’s got pharma’s back in global pandemic treaty negotiations
For those countries and their advocates, it’s a striking stance — given what happened after Covid arrived: They shared data about new variants only to…